Reunion Neuroscience (REUN) Announces $10M At-The-Market Equity Facility
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/1/2026
- Wall St on track for subdued September start as high yields, oil prices dent sentiment
- Oil up more than 2% as renewed US-Iran strikes stoke supply fears
- Two Saudi tankers struck in Strait of Hormuz Monday
- Fed’s Barr backs rate hike if inflation fails to cool, September odds hit 66%
- The Warsh pivot markets didn't expect
Reunion Neuroscience Puts in Place At-The-Market Equity Facility
November 18, 2022 5:05 PM ESTTORONTO, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Reunion Neuroscience Inc. (TSX: REUN, NASDAQ: REUN) ("Reunion" or the Company), a biopharmaceutical company committed to developing innovative and patented therapeutic solutions for underserved mental health conditions, today announced that it has entered into an equity distribution agreement with Canaccord Genuity to establish an at-the-market equity facility.
Pursuant to the at-the-market equity facility (ATM Facility), the Company may, at its discretion sell up to US$10,000,000 of its common shares through at-the-market issuances on the Nasdaq Stock Market in the United States. No... More
